(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium has been researched along with dodecanol in 1 studies
| Studies ((3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium) | Trials ((3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium) | Recent Studies (post-2010) ((3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium) | Studies (dodecanol) | Trials (dodecanol) | Recent Studies (post-2010) (dodecanol) |
|---|---|---|---|---|---|
| 52 | 3 | 1 | 233 | 1 | 88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, SH; Felgner, PL; Manthorpe, M; Marshall, J; Sukhu, L; Tsai, YJ; Wheeler, CJ | 1 |
1 review(s) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and dodecanol
| Article | Year |
|---|---|
Improved cationic lipid formulations for in vivo gene therapy.
Topics: Animals; beta-Galactosidase; Cation Exchange Resins; Cations; Chloramphenicol O-Acetyltransferase; DNA, Recombinant; Dodecanol; Drug Administration Routes; Drug Carriers; Genes, Reporter; Genetic Therapy; Genetic Vectors; Lipids; Liposomes; Luciferases; Macromolecular Substances; Mice; Mice, Inbred BALB C; Myristic Acids; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Recombinant Fusion Proteins; Transfection | 1995 |